F. X. Weilbach

482 total citations
20 papers, 311 citations indexed

About

F. X. Weilbach is a scholar working on Pathology and Forensic Medicine, Physical Therapy, Sports Therapy and Rehabilitation and Immunology. According to data from OpenAlex, F. X. Weilbach has authored 20 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 5 papers in Physical Therapy, Sports Therapy and Rehabilitation and 4 papers in Immunology. Recurrent topics in F. X. Weilbach's work include Multiple Sclerosis Research Studies (8 papers), Stroke Rehabilitation and Recovery (3 papers) and Medical Practices and Rehabilitation (3 papers). F. X. Weilbach is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Stroke Rehabilitation and Recovery (3 papers) and Medical Practices and Rehabilitation (3 papers). F. X. Weilbach collaborates with scholars based in Germany and Slovakia. F. X. Weilbach's co-authors include Andrew Chan, Ralf Gold, Klaus V. Toyka, Klaus V. Toyka, K. V. Toyka, Sonja C. Kleih, R. Gold, Roland Goldbrunner, Thomas Günthner‐Lengsfeld and Martin Koltzenburg and has published in prestigious journals such as Circulation, The American Journal of Cardiology and Frontiers in Human Neuroscience.

In The Last Decade

F. X. Weilbach

18 papers receiving 299 citations

Peers

F. X. Weilbach
Nicola Bertolino United States
Helle Juhl Simonsen Denmark
Luigi Ferrante Italy
Hayoung Byun South Korea
Saša Šega Slovenia
Payal Naik United States
Elisabeth B. Lucassen United States
Liangjuan Fang China
E. Reggio Italy
Alessandro Dinoto Italy
Nicola Bertolino United States
F. X. Weilbach
Citations per year, relative to F. X. Weilbach F. X. Weilbach (= 1×) peers Nicola Bertolino

Countries citing papers authored by F. X. Weilbach

Since Specialization
Citations

This map shows the geographic impact of F. X. Weilbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. X. Weilbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. X. Weilbach more than expected).

Fields of papers citing papers by F. X. Weilbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. X. Weilbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. X. Weilbach. The network helps show where F. X. Weilbach may publish in the future.

Co-authorship network of co-authors of F. X. Weilbach

This figure shows the co-authorship network connecting the top 25 collaborators of F. X. Weilbach. A scholar is included among the top collaborators of F. X. Weilbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. X. Weilbach. F. X. Weilbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weilbach, F. X., et al.. (2020). Implementation of a gait center training to improve walking ability and vital parameters in inpatient neurological rehabilitation- a cohort study. Journal of NeuroEngineering and Rehabilitation. 17(1). 6 indexed citations
2.
Roth, Daniel, et al.. (2019). Physiological Effectivity and User Experience of Immersive Gait Rehabilitation. 15 indexed citations
3.
Gall, Dominik, et al.. (2018). Immersive Robot-Assisted Virtual Reality Therapy for Neurologically-Caused Gait Impairments. 565–566. 11 indexed citations
4.
5.
6.
Chan, Andrew, Vera Hummel, F. X. Weilbach, Bernd C. Kieseier, & Ralf Gold. (2006). Phagocytosis of apoptotic inflammatory cells downregulates microglial chemoattractive function and migration of encephalitogenic T cells. Journal of Neuroscience Research. 84(6). 1217–1224. 14 indexed citations
7.
Chan, Andrew, F. X. Weilbach, Klaus V. Toyka, & Ralf Gold. (2004). Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients. Clinical & Experimental Immunology. 139(1). 152–158. 72 indexed citations
8.
Bendszus, Martin, Martin Koltzenburg, Andreas J. Bartsch, et al.. (2004). Heparin and Air Filters Reduce Embolic Events Caused by Intra-Arterial Cerebral Angiography. Circulation. 110(15). 2210–2215. 62 indexed citations
9.
Spindler, Matthias, F. X. Weilbach, Meinrad Beer, et al.. (2003). Non-Invasive Functional and Biochemical Assessment of Mitoxantrone Cardiotoxicity in Patients with Multiple Sclerosis. Journal of Cardiovascular Pharmacology. 42(5). 680–687. 8 indexed citations
10.
Weilbach, F. X., Andrew Chan, K. V. Toyka, & R. Gold. (2003). The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis. Clinical & Experimental Immunology. 135(1). 49–55. 33 indexed citations
11.
Spindler, Matthias, et al.. (2002). Myocardial function in patients with multiple sclerosis treated with low-dose mitoxantrone. The American Journal of Cardiology. 89(10). 1222–1225. 17 indexed citations
12.
Weilbach, F. X. & Klaus V. Toyka. (2002). Does Down’s Syndrome Protect against Multiple Sclerosis?. European Neurology. 47(1). 52–55. 11 indexed citations
13.
Petereit, H.-F., et al.. (2002). Die DRGs als zukünftiges Abrechnungssystem der Krankenhausleistungen am Beispiel der Multiplen Sklerose. Der Nervenarzt. 73(8). 785–791. 1 indexed citations
14.
Weilbach, F. X., et al.. (1999). Aktuelle Diagnostik bei Muskeldystrophien. Der Nervenarzt. 70(2). 89–100. 1 indexed citations
15.
Weilbach, F. X. & Ralf Gold. (1999). Disease Modifying Treatments for Multiple Sclerosis. CNS Drugs. 11(2). 133–157. 7 indexed citations
16.
Weilbach, F. X., Steffen Jung, Hans‐Peter Hartung, K. V. Toyka, & Gerhard Giegerich. (1997). T-cell receptor Vβ-element expression in peripheral nerves of Lewis rats suffering from experimental autoimmune neuritis. Journal of Neuroimmunology. 79(1). 69–75. 6 indexed citations
17.
Weilbach, F. X. & Hans‐Peter Hartung. (1997). Physikalisches Trauma und multiple Sklerose. Der Nervenarzt. 68(12). 940–944. 3 indexed citations
18.
Weilbach, F. X. & HP Hartung. (1996). Immunmodulation bei multipler Sklerose: Linomide. Der Nervenarzt. 67(8). 701–705.
19.
Weilbach, F. X. & Hans‐Peter Hartung. (1995). [Cladribine in chronic progressive multiple sclerosis].. PubMed. 66(4). 299–303.
20.
Weilbach, F. X., Ulrich Bogdahn, Martin Poot, et al.. (1990). Melanoma-inhibiting activity inhibits cell proliferation by prolongation of the S-phase and arrest of cells in the G2 compartment.. PubMed. 50(21). 6981–6. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola Bertolino Breakdown of academic impact, for papers by Helle Juhl Simonsen Breakdown of academic impact, for papers by Luigi Ferrante Breakdown of academic impact, for papers by Hayoung Byun Breakdown of academic impact, for papers by Saša Šega Breakdown of academic impact, for papers by Payal Naik Breakdown of academic impact, for papers by Elisabeth B. Lucassen Breakdown of academic impact, for papers by Liangjuan Fang Breakdown of academic impact, for papers by E. Reggio Breakdown of academic impact, for papers by Alessandro Dinoto
Rankless by CCL
2026